Trexgen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-07-2024
- Paid Up Capital ₹ 0.10 M
as on 18-07-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 21.78%
(FY 2023)
- Profit 180.16%
(FY 2023)
- Ebitda 33.79%
(FY 2023)
- Net Worth 9.77%
(FY 2023)
- Total Assets 13.33%
(FY 2023)
About Trexgen Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pankajbhai Vekariya, Piyush Vekaria, Bharatkumar Vekariya, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2013PTC074587
- Company No.
074587
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Trexgen Pharmaceuticals Private Limited offer?
Trexgen Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Bone, Joint & Muscle Care, Popular Category, Bone & Joint Care, Mind Care, Heart Care.
Who are the key members and board of directors at Trexgen Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankajbhai Vekariya  | Director | 19-Apr-2013 | Current |
| Piyush Vekaria | Director | 19-Apr-2013 | Current |
| Bharatkumar Vekariya | Director | 05-Sep-2014 | Current |
| Karshanbhai Vekaria | Director | 05-Sep-2014 | Current |
| Mayur Vekaria | Director | 05-Sep-2014 | Current |
| Vithalbhai Vekariya | Director | 05-Sep-2014 | Current |
Financial Performance of Trexgen Pharmaceuticals.
Trexgen Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.78% increase. The company also saw a substantial improvement in profitability, with a 180.16% increase in profit. The company's net worth moved up by a moderate rise of 9.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trexgen Pharmaceuticals?
In 2023, Trexgen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trexchem Organosys Private LimitedActive 11 years 5 monthsPankajbhai Vekariya, Piyush Vekaria and 4 more are mutual person
Jetpur Dyeing And Printing AssociationActive 13 years 2 monthsBharatkumar Vekariya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trexgen Pharmaceuticals?
Trexgen Pharmaceuticals has a workforce of 2 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trexgen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trexgen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
